Pulmokine, Inc.
Biotechnology company · Rensselaer, New York, United States
Pulmokine, Inc. is a biotechnology company headquartered in Rensselaer, New York, United States. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $7 million in total, most recently in 2017.
Pulmokine at a glance
What does Pulmokine do?
US government research funding
7 SBIR/STTR small-business research awards from US health agencies, $7 million in total (2010 to 2017). NIH funding came from the National Heart, Lung, and Blood Institute.
Frequently asked questions about Pulmokine
Where is Pulmokine headquartered?
Pulmokine, Inc. is headquartered in Rensselaer, New York, United States.
What does Pulmokine do?
Pulmokine, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences